This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Shewta Singh: Innovator in Antibody Therapeutics
Introduction
Shewta Singh is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Shewta Singh holds a patent for Anti-CD38 antibodies. This patent discloses isolated antibodies that bind to human CD38 and cynomolgus CD38. Additionally, it includes pharmaceutical compositions comprising these antibodies, along with therapeutic and diagnostic methods for their use. This innovation represents a significant advancement in antibody-based therapies.
Career Highlights
Shewta Singh is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. Her role involves research and development in the field of antibody therapeutics, where she applies her expertise to create impactful medical solutions.
Collaborations
Shewta collaborates with esteemed colleagues, including Gregory M Landes and Mary Haak-Frendscho. These partnerships enhance the research and development process, fostering innovation and progress in their projects.
Conclusion
In summary, Shewta Singh is a dedicated inventor whose work in antibody therapeutics is paving the way for new treatment options. Her contributions to the field are invaluable, and her patent on Anti-CD38 antibodies exemplifies her commitment to advancing medical science.